Kisung Nam

Seoul National University
Country flagSouth Korea

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (12)

Year:

2026

Year:

2026

Background Data on associations between genetic predisposition to high blood pressure (BP) and hypertension and its complications in non‐European populations are limited. The current study investigated associations between polygenic risk scores (PRSs) for BP and risks of hypertension, cardiovascular disease, and chronic kidney disease in Northeast Asian populations. Methods A genome‐wide association study of systolic BP (SBP) and diastolic BP (DBP) was conducted using data from the KoGES (Korean Genome and Epidemiology Study). Results were meta‐analyzed using summary statistics from Biobank Japan to construct PRSs. Results Compared with a PRS in the lowest 5 percentiles, a PRS in the highest 5 percentiles was associated with an increased risk of hypertension (hazard ratio [HR], 2.44 [95% CI, 1.67–3.56] for PRS for SBP; and HR, 1.77 [95% CI, 1.20–2.62] for PRS for DBP) and earlier onset of hypertension (by a median of 8.5 years for PRS for SBP and 8.0 years for PRS for DBP). These associations remained significant when continuous PRS was analyzed. The genetic risk of hypertension incidence was attenuated by moderate to vigorous physical activity. Adding the PRS for BP to the clinical risk factors improved the predictive value for hypertension (both area under the curve values, 0.787 [95% CI, 0.771–0.803]; P =0.063 for PRS for SBP and [95% CI, 0.771–0.804]; P =0.031 for PRS for DBP). However, neither PRS for SBP nor PRS for DBP was associated with the incidence of cardiovascular or chronic kidney disease. Conclusions The PRS for BP was associated with a higher risk of incident hypertension and earlier‐onset hypertension in a Northeast Asian population. PRS may facilitate early identification and targeted management of individuals at high risk of developing hypertension.

Year:

2026

Year:

2025

Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.

Year:

2024

Due to their low frequency, estimating the effect of rare variants is challenging. Here, we propose RareEffect, a method that first estimates gene- or region-based heritability and then each variant effect size using an empirical Bayes approach. Our method uses a variance component model, popular in rare variant tests, and is designed to provide two levels of effect sizes, gene/region-level and variant-level, which can provide better interpretation. To adjust for the case-control imbalance in phenotypes, our approach uses a fast implementation of the Firth bias correction. We demonstrate the accuracy and computational efficiency of our method through extensive simulations and the analysis of UK Biobank whole exome sequencing data for 100 traits. Additionally, we show that the effect sizes obtained from our model can be leveraged to improve the performance of polygenic scores, outperforming recently developed methods for rare variant polygenic scoring.

Year:

2024

Large-scale whole-genome sequencing (WGS) data provides unprecedented opportunity to explore the role of rare variants in non-coding regions on complex traits. However, unlike gene-based exome analysis, non-coding regions lack a well-defined unit for rare-variant testing. Here, we utilized 1,036,913 candidate Cis-Regulatory Elements (cCREs) from ENCODE as analysis units and conducted rare-variant association analysis for 100 traits with SAIGE-GENE+. In a discovery set of 150K White-British samples we identified 1,987 significant associations and replicated 88% of them in a validation set of 250K White-British samples. Associations were enriched in promoter-like signals (PLS) and proximal enhancer- like signals (pELS). Conditional analyses of 230 cCREs across five traits on GWAS variants identified 68 independent cCRE associations. A leukemia case study highlighted key loci, including a PLS for SRSF2 and a pELS for BCL6, demonstrating the effectiveness of cCRE- based analysis.

Year:

2024

A meta-analysis is a practical approach to increasing the power of rare variant tests by combining summary statistics from multiple cohorts. However, existing methods for rare variant meta-analysis often fail to correctly control type I error rates when analyzing low-prevalence binary traits and are computationally intensive when analyzing many phenotypes. This paper introduces Meta-SAIGE, a novel approach for rare variant meta-analyses that addresses these challenges. Meta-SAIGE reduces type I error inflation through precise estimation of the distribution of test statistics and allows the reuse of the linkage disequilibrium (LD) matrix across phenotypes, significantly improving computational efficiency for phenome-wide analyses. Simulation studies using UK Biobank whole-exome sequencing (WES) genotypes demonstrate that Meta-SAIGE effectively controls type I error rates and yields power similar to that of pooled individual-level data through SAIGE-GENE+. A meta-analysis of UK Biobank and All of Us WES data for 83 low prevalence disease phenotypes identified 237 associations. Notably, 80 of these associations were not significant in either dataset alone, underscoring the power of our meta-analysis.

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (43)

Xiaofeng Zhu

Professor

Case Western Reserve University

UNITED STATES
View details

Harold Snieder

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Jin Man Kim

Assistant Professor

Seoul National University

SOUTH KOREA
View details

Amy Bentley

National Human Genome Research Institute

UNITED STATES
View details

Cristina Menni

King’s College London

UNITED KINGDOM
View details

Nicholas Wareham

Director

University of Cambridge

UNITED KINGDOM
View details

Joseph McCormick

James H. Steele Professor

-

UNITED STATES
View details

Bhramar Mukherjee

-

UNITED STATES
View details

Seunggeun Lee

Professor

Seoul National University

SOUTH KOREA
View details

Dokyoon Kim

Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Vilmundur Gudnason

Professor

University of Iceland

ICELAND
View details

Simon R. Cox

Personal Chair of Brain and Cognitive Ageing

University of Edinburgh

UNITED KINGDOM
View details

Jennifer Ann Smith

Professor

University of Michigan

UNITED STATES
View details

Sarah Harris

University of Edinburgh

UNITED KINGDOM
View details

Ching-Ti Liu

Boston University

UNITED STATES
View details

Ko Willems van Dijk

Professor

Leiden University Medical Center

NETHERLANDS
View details

massimo mangino

Honorary Senior Lecturer

King’s College London

UNITED KINGDOM
View details

Heming Wang

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Ilja Nolte

Senior Researcher of Statistical Genetics and Genetic Epidemiology

University Medical Center Groningen

NETHERLANDS
View details

Heather M Highland

University of North Carolina at Chapel Hill

UNITED STATES
View details

Marcus Dörr

University Medicine Greifswald

GERMANY
View details

Paul de Vries

Assistant Professor

The University of Texas Health Science Center at Houston School of Public Health

UNITED STATES
View details

Lisa de las Fuentes

Professor of Medicine and Biostatistics

Washington University School of Medicine

UNITED STATES
View details

Iris M. Heid

University of Regensburg

GERMANY
View details

Rodney Scott

Prof. of Medical Genetics

University of Newcastle Australia

AUSTRALIA
View details

Myriam Fornage

-

UNITED STATES
View details

Changwei Li

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Mary Feitosa

Associate Professor

Washington University School of Medicine

UNITED STATES
View details

Debbie A Lawlor

Academic , Professor of Epidemiology, MRC Investigator and BHF Chair

University of Bristol

UNITED KINGDOM
View details

Sami Heikkinen

Research Director

University of Eastern Finland

FINLAND
View details

Peter Y Liu

University of California

UNITED STATES
View details

Kari North

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Michael Province

Professor, Head Division of Statistical Genomics

Washington University in St. Louis

UNITED STATES
View details

Uwe Völker

Professor, Head of Department

Universitätsmedizin Greifswald

GERMANY
View details

Quan Sun

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

John Attia

University of Newcastle Australia

AUSTRALIA
View details

Sung-Jin Kim

Assistant Professr

Seoul National University

SOUTH KOREA
View details

Nicholette Allred

Wake Forest Baptist Medical Center

UNITED STATES
View details

Mariaelisa Graff

Assistant Professor

University of North Carolina

UNITED STATES
View details

Brian Cade

Investigator

Brigham and Women's Hospital

UNITED STATES
View details

Terho Lehtimäki

University of Tampere

FINLAND
View details

SINA A. GHARIB

University of Washington

UNITED STATES
View details

Jian'an Luan

University of Cambridge

UNITED KINGDOM
View details